Fairvalue-Calculator Fairvalue-Calculator
EN DE

Oncoclínicas do Brasil Serviços Médicos S.A (ONCO3) Fair Value & Analysis

Healthcare · BR · Market cap R$1.4B

PriceR$1.35
Fair ValueR$0.4800
Upside-64.4%
Quality92/100
Evidence: Low Range R$0.2600 – R$0.6700

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Oncoclínicas do Brasil Serviços Médicos S.A (ONCO3) currently trades at R$1.35, while our model-based Fair Value estimate is R$0.4800 — implying the stock looks roughly 64.4% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Oncoclínicas do Brasil Serviços Médicos S.A., together with its subsidiaries, provides oncology, hematology, radiotherapy, and genomics healthcare services in Latin America. The company offers treatment services, including radiotherapy, hormone therapy, immunotherapy, port-a-cath, palliative care, target therapy, breast cancer hormone therapy, bone marrow transplant, non-oncological infusions, chemotherapy, oral chemotherapy, and prostate cancer hormone therapy; and surgery procedures, such as breast, head and neck, lung, prostate cancer, stomach, bladder cancer, oncological, kidney cancer, gynecological, and testicular cancer. It also provides diagnostics services comprising pathological analysis, genetic testing, molecular journey, personalized medicine and individualized treatment, myelogram-bone marrow biopsy, and ONCO test-PDO. In addition, the company offers treatment support services, which include veinviewer, cryotherapy, integrative medicine, and DeLife, as well as hilother…

Open the full interactive analysis →

Similar stocks

HCA Healthcare, Inc (H1CA34) +29% Fresenius SE (FSNUY) -24% 5225 (5225) -39% IHHHF (IHHHF) -57% Rede D'Or São Luiz S.A (RDOR3) +37% Tenet Healthcare Corporation (THC) +68%

Frequently asked questions

Is Oncoclínicas do Brasil Serviços Médicos S.A (ONCO3) undervalued?
As of Jun 25, 2026, our model estimates a fair value of R$0.4800 versus a price of R$1.35 — about −64% (overvalued). Model-based estimate, not financial advice.
What is the fair value of ONCO3?
Our 21-model fair value for Oncoclínicas do Brasil Serviços Médicos S.A is R$0.4800 (as of Jun 25, 2026), built from audited fundamentals. The current price is R$1.35.
What is the quality score of ONCO3?
Oncoclínicas do Brasil Serviços Médicos S.A has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.